Back to search

Bridging Pharma Ltd

09359212

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

3RD FLOOR, LONDON, EC3N 1LQ
Incorporated 17/12/2014

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

96090
Other personal service activities

Officers

Dr Huai Zheng Peng

director · Since 17/12/2014

DIRECTOR

BRITISH · ENGLAND · Age 63

Also on 1 other board

CompanyRankvs 53075+ SIC 96090 peers
39

Financial strength35th percentile among SIC peers · 9/25
Employees16th percentile among SIC peers · 2/15
LiquidityCurrent ratio 1.35× · 12/20
Longevity11 years trading (max 15) · 11/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength9/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees2/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity11/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the director with respect to going con

Key FinancialsYear ending 31/12/2025

Turnover

£109k

Annual revenue

Net Worth

£100

Balance sheet strength

Cash

£47k

Cash in the bank

Profit Before Tax

£11k

Bottom line earnings

Net Current Assets

£24k

Working capital

Current Assets

£95k

Current Liabilities

£70k

Debtors

£48k

Admin Expenses

£99k

Profit After Tax

£7k

0avg. employees-1

Tax at Year End

Corp tax£3k

Balance Sheet

Assets less current liabilities£24k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20251.35
20241.09
20230.59
20220.56
20210.59
20200.57
20190.45

Derived from filed accounts. Not audited figures.